Literature DB >> 1648703

Flg-2, a new member of the family of fibroblast growth factor receptors.

A Avivi1, Y Zimmer, A Yayon, Y Yarden, D Givol.   

Abstract

Two genes, flg and bek, have been recently shown to encode receptors for fibroblast growth factors (FGF). Here we report the molecular cloning and sequence of a new member of the FGF receptor family, denoted flg-2, which was isolated from a human keratinocyte cDNA library. The cDNA sequence predicts an extracellular region possessing three immunoglobulin-like domains, a single transmembrane region and a cytoplasmic portion containing the tyrosine kinase domain split by a short inter-kinase segment. The amino acid sequence of flg-2 shows 68% and 64% identity with bek and flg, respectively. The most variable domain among the three genes is the amino-terminal immunoglobulin-like domain. Comparison with the chicken FGF receptor genes suggests that flg-2 is homologous to cek-2, whereas flg and bek are homologous to cek-1 and cek-3, respectively. Analysis of mRNA from various tissues shows that flg-2 is expressed predominantly in skin, brain and lung.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648703

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

Review 2.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

3.  A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.

Authors:  Y Wang; M K Spatz; K Kannan; H Hayk; A Avivi; M Gorivodsky; M Pines; A Yayon; P Lonai; D Givol
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 4.  Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia.

Authors:  M C Le Bousse-Kerdilès; M C Martyré
Journal:  Springer Semin Immunopathol       Date:  1999

5.  Postnatal regulation of fibroblast growth factor ligand and receptor gene expression in rat thoracic aorta.

Authors:  J A Winkles; G F Alberts; K A Peifley; K Nomoto; G Liau; M W Majesky
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

6.  Upregulation of fibroblast growth factor-receptor messenger RNA expression in rat brain following transient forebrain ischemia.

Authors:  K Takami; Y Kiyota; M Iwane; M Miyamoto; R Tsukuda; K Igarashi; A Shino; A Wanaka; S Shiosaka; M Tohyama
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

7.  Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors.

Authors:  W Casscells; D A Lappi; B B Olwin; C Wai; M Siegman; E H Speir; J Sasse; A Baird
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

8.  Growth Factors.

Authors:  Ricardo V. Lloyd
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

9.  A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.

Authors:  A Yayon; Y Zimmer; G H Shen; A Avivi; Y Yarden; D Givol
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

10.  Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate.

Authors:  B B Olwin; A Rapraeger
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.